share_log

Recap: Atea Pharmaceuticals Q4 Earnings

Benzinga ·  Feb 28 16:35

Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Atea Pharmaceuticals beat estimated earnings by 6.0%, reporting an EPS of $-0.47 versus an estimate of $-0.5.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 9.0% drop in the share price the next day.

To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment